Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

NCT05800366

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Miami Sylvester Cancer Center Miami, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

NCT03683433

Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Bone Marrow Diseases, +25 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

NCT04375631

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +27 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

NCT05640102

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Clearview Cancer Institute Huntsville, Alabama, United States

South Alabama Medical Science Foundation Mitchell Cancer Institute Mobile, Alabama, United States

City of Hope National Medical Center Duarte, California, United States

Los Angeles Cancer Network (Lacn) Glendale, California, United States

View Trial Details

Recruiting

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

NCT01788839

Conditions: Behavior, Breast Cancer, Breast Diseases, +16 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

View Trial Details

Recruiting

Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL

NCT07154043

Conditions: BCRL, Breast Cancer Lymphedema, Breast Cancer-Related Lymphedema, +6 more
Locations: Pamukkale University Denizli, Turkey (Türkiye)

View Trial Details

Recruiting

Orelabrutinib Combined With Rituximab ± Lenalidomide in Response-Adapted Stratified Therapy for Untreated MZL

NCT07448324

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

NCT07294677

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Recruiting

A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

NCT06486051

Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Christchurch Hospital Christchurch, Christchurch Central, New Zealand

Wellington Hospital Newtown, Wellington Region, New Zealand

Auckland City Hospital Auckland, New Zealand

View Trial Details

Recruiting

A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT05950165

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Tri-Service General Hospital - Neihu Branch - Hematology Taipei, Taiwan

Taipei Medical University - Shuang Ho Hospital - Oncology New Taipei City, Taipei Special Municipality, Taiwan

National Taiwan University Hospital Yunlin Branch Huwei, Taiwan

Chi-Mei Medical Center Tainan, Taiwan

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions